30 November 2020 in Aesthetic Surgery Journal
Background: Current literature clearly outlines the complication rates of liposuction in general; however, data specific to large-volume liposuction (LVL) remain unclear. Objectives: The authors aimed to synthesize the current evidence on the safety of LVL with this systematic review. Methods: A comprehensive search in the MEDLINE, EMBASE, and CENTRAL databases was conducted for primary clinical studies reporting on safety or complications related to aesthetic LVL from 1946 to March 2020. The primary outcome measure was the incidence of surgical complication, and the secondary outcome measure was changes in metabolic profile. Meta-analyses were conducted to pool the estimated surgical complication incidence and metabolic changes. Results: Twenty-three articles involving 3583 patients were included. The average aspirate volume was 7734.90 mL (95% CI = 5727.34 to 9742.45 mL). The pooled overall incidence of major surgical complications was 3.35% (95% CI = 1.07% to 6.84%). The most common major complication was blood loss requiring transfusion (2.89% [95% CI = 0.84% to 6.12%]) followed by pulmonary embolism (0.18% [95% CI = 0.06% to 0.33%]), hematoma (0.16% [95% CI = 0.05% to 0.32%]), necrotizing fasciitis (0.13% [95% CI = 0.04% to 0.29%]), and deep vein thrombosis (0.12% [95% CI = 0.03% to 0.27%]). No fat embolism or death was reported in the included studies. The pooled overall incidence of minor surgical complication was 11.62% (95% CI = 6.36% to 18.21%), with seroma being the most common minor complication (5.51% [95% CI = 2.69% to 9.27%]). Reductions in lipid profile, glucose profile, body weight, and hematocrit level were observed after LVL. Conclusions: The authors meta-analyzed and highlighted the complication rates specifically related to LVL in this study; however, the current data are limited by the lack of level 1 evidence. Level of Evidence: 4:
13 September 2022 in The International Journal of Medical Robotics and Computer Assisted Surgery
19 May 2025 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Robotic or robotic assisted surgery offers notable advantages in the operating theatre, particularly improved ergonomics and reduced mental and physical workload compared to laparoscopic surgery. This review assessed the feasibility of robotic surgery in abdominal wall reconstruction and hernia repair, as well as the barriers to clinical implementation and training. Conducted in accordance with preferred reporting items for systematic reviews and meta-analyses guidelines, this systematic review included a literature search of PubMed, Medline, and Embase databases. Descriptive synthesis and mixed fixed/random effects meta-analysis were performed, with unpaired t-tests used for nonparametric data. A total of 110 clinical and 4 educational articles were reviewed. Robotic surgery was associated with longer operative times than laparoscopic and open approaches, though steep learning curves were commonly reported. However, robotic surgery showed a significantly shorter hospital stay (mean difference: -1.59 days, 95% CI: -1.89 to -1.30) and fewer complications compared to open surgery (OR: 0.75, 95% CI: 0.56-1.01). When compared with laparoscopic surgery, robotic procedures showed a trend towards fewer complications (OR: 0.87, 95% CI: 0.56-1.37). Although robotic procedures incur higher costs than laparoscopic surgery, the overall cost may be balanced by faster recovery and fewer complications when compared to open surgery. In conclusion, robotic and robotic assisted surgery are technically feasible and safe for abdominal wall reconstruction. Further high-quality comparative studies, especially against laparoscopic surgery, are needed to justify higher costs and fully evaluate the patient care benefits.
10 December 2020 in Research Square
BackgroundThe use of mixed and augmented reality in surgery is a novel and rapidly developing field. Augmented reality is a technology which overlays virtual images on to the real world and is supported by a variety of platforms. Mixed reality is a newer technology, which, in contrast, allows the user to interact with virtual objects projected onto the real world. These technologies have been employed in a range of surgical contexts and specialities and have generated significant public interest, however, the evidence supporting their proposed benefits is unclear. This systematic review aims to critically appraise the intraoperative use of mixed and augmented reality technologies to improve surgical outcomes and provide directions for future research. Methods This systematic review will follow the PRISMA guidelines and search the MEDLINE, EMBASE, the Cochrane Library electronic databases. All clinical studies reporting empirical data on the intraoperative use of augmented or mixed reality technologies will be eligible for inclusion. Identified studies will be screened for inclusion by three authors in parallel, with a fourth author resolving any discrepancies. Risk of bias will be assessed in accordance with Cochrane Handbook for Systematic Reviews of Interventions guidance. The quality of evidence for each outcome will be assessed using the GRADE approach.DiscussionThis will be the first systematic review performed with a specific focus on the use of mixed reality in surgery. If augmented and mixed reality are to become established tools in surgery, it is necessary to understand their use cases, advantages, limitations and cost-effectiveness. This is a young but rapidly evolving field; this synthesis of the current evidence base will provide direction for future research and development.Systematic Review RegistrationPROSPERO CRD42020205892